Conference Archives:
- Controlling the HIV Epidemic Summit 2022
- Controlling the HIV Epidemic Summit 2018
- Controlling the HIV Epidemic Summit 2016
- Controlling the HIV Epidemic Summit 2015
- Controlling the HIV Epidemic Summit 2014
- Controlling the HIV Epidemic Summit 2013
- Controlling the HIV Epidemic Summit 2012
- Controlling the HIV Epidemic Summit
NOVEMBER 30, 2022
WELCOME REMARKS
Welcome from IAPAC
Welcome from UNAIDS
THEMATIC SESSION: HIV RESPONSE METRICS
Defining HIV Epidemic Control at Urban, National, and Global Levels
THEMATIC SESSION: HIV SERVICE DELIVERY
Community Differentiated Service Delivery Models to Improve Continuity of HIV Treatment
Avoiding Failure: Designing a Coordinated HIV Service Delivery Systems
THEMATIC SESSION: KEY POPULATIONS
Barrier or Facilitator: What is the Overall State of National Harm Reduction Policies?
Defining Successful Aging for People Living with Chronic Diseases and HIV
Stigma as Barrier to HIV Treatment Adherence among Men who have Sex with Men who use Crystal Meth
Household Economic Strengthening to Improve Antiretroviral Therapy Adherence
DECEMBER 1, 2022
WORLD AIDS DAY 2022 REMARKS
THEMATIC SESSION: HIV STIGMA/HEALTH EQUITY
U=U is a Win Win
Ending Stigma, Advancing Equity: Leveraging Political Will at the Local and State Levels
THEMATIC SESSION: HIV SCREENING/TESTING
Sustained Opt-Out HIV Testing in Emergency Department Settings
Eliminating Barriers to and Improving Early HIV Diagnosis
THEMATIC SESSION: HIV BIOMEDICAL PREVENTION
Adopting a Status-Neutral Approach for Biomedical HIV Prevention
Over-the-Counter PrEP: Opening the Floodgates to Empower Patients
Increasing Awareness and Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP)
THEMATIC SESSION: HIV/HEALTH FINANCING
Cabotegravir: Global Access for Long-Acting Pre-Exposure Prophylaxis for HIV
CLOSING REMARKS
NOTE: The concepts, ideas, and innovations presented at the Summit represent the opinions and views of the presenters and not necessarily the views of IAPAC, UNAIDS, or the summit’s corporate sponsors.